Fernanda da Silva Rodrigues
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Fernanda da Silva Rodrigues has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Renata Padilha Guedes
Graduate Program in Biosciences, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, Brazil
4 shared publications - Cristiane Regina Guerino Furini
Pontifícia Universidade Católica do Rio Grande do Sul – Porto Alegre – Rio Grande do Sul – Brasil
2 shared publications - Isadora Tassinari
Laboratory of Neurobiology and Metabolism (NeuroMet), Department of Physiology, Institute for Basic Health Sciences, Federal University of Rio Grande do Sul, Porto Alegre 90035-003, Brazil
2 shared publications - Ivan Izquierdo
Memory Center, Brain Institute of Rio Grande do Sul, Pontifical Catholic University of Rio Grande do Sul (PUCRS), Av. Ipiranga, 6690 - 2nd Floor, 90610-000 Porto Alegre, RS, Brazil; National Institute of Translational Neuroscience (INNT), National Research Council of Brazil, Brazil
2 shared publications - Jociane de Carvalho Myskiw
Memory Center, Brain Institute of Rio Grande do Sul, Pontifical Catholic University of Rio Grande do Sul (PUCRS), Av. Ipiranga, 6690 - 2nd Floor, 90610-000 Porto Alegre, RS, Brazil; National Institute of Translational Neuroscience (INNT), National Research Council of Brazil, Brazil
2 shared publications - Luciano Stürmer de Fraga
Graduate Program in Physiology, Institute of Basic Health Sciences (ICBS), Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, Brazil
2 shared publications
Latest Publications
- 20 July 2026
- Published by Wiley in Journal of Neuroendocrinology
- Vol. 38 (7) , e70234
Effects of cannabidiol in comparison to hormonal therapy on estrogen decline‐induced memory impairments and endocannabinoid system in rats
The aim of this study was to investigate the effects of cannabidiol (CBD) on memory deficits induced by ovariectomy and to directly compare its effects with those of hormone therapy, in order to better understand potential shared mechanisms related to menopause‐associated cognitive decline, with a particular focus on the endocannabinoid system. Three‐month‐old female Wistar rats were randomly assigned to four experimental groups: SHAM‐Veh (Vehicle), OVX‐Veh, OVX‐E2 (estradiol), and OVX‐CBD. Animals underwent either bilateral ovariectomy or sham surgery. Following a three‐week recovery period, rats received daily subcutaneous injections of CBD (10 mg/kg), estradiol (10 μg/kg), or vehicle for 21 consecutive days. Behavioral assessments included object recognition and fear‐motivated memory tests. Twenty‐four hours after the final treatment, animals were euthanized for neurochemical and molecular analyses. Levels of the endocannabinoids anandamide (AEA) and 2‐arachidonoylglycerol (2‐AG) were measured using high‐performance liquid chromatography. Gene expression of cannabinoid receptors CB1 and CB2, as well as enzymes involved in the synthesis and degradation of endocannabinoids (NAPE‐PLD, DAGL‐A, FAAH, and MGLL), was evaluated in the hippocampus by RT‐qPCR. The results demonstrated that CBD treatment produced memory improvements in the object recognition task comparable to those observed with estradiol. Ovariectomy‐induced impairments in fear‐motivated memory were completely reversed by both CBD and estradiol treatments. Additionally, CBD reduced the expression of FAAH and MGLL, resulting in increased hippocampal levels of AEA and 2‐AG, effects similar to those observed with hormone therapy. Estradiol also increased NAPE‐PLD expression, contributing to elevated AEA levels. Overall, the findings suggest that CBD exerts a protective effect on memory comparable to standard estrogen therapy, supporting its therapeutic potential for menopause‐related cognitive impairments.
- 20 July 2026
- Published by Wiley in Journal of Neuroendocrinology
- Vol. 38 (7) , e70234
Effects of cannabidiol in comparison to hormonal therapy on estrogen decline‐induced memory impairments and endocannabinoid system in rats
The aim of this study was to investigate the effects of cannabidiol (CBD) on memory deficits induced by ovariectomy and to directly compare its effects with those of hormone therapy, in order to better understand potential shared mechanisms related to menopause‐associated cognitive decline, with a particular focus on the endocannabinoid system. Three‐month‐old female Wistar rats were randomly assigned to four experimental groups: SHAM‐Veh (Vehicle), OVX‐Veh, OVX‐E2 (estradiol), and OVX‐CBD. Animals underwent either bilateral ovariectomy or sham surgery. Following a three‐week recovery period, rats received daily subcutaneous injections of CBD (10 mg/kg), estradiol (10 μg/kg), or vehicle for 21 consecutive days. Behavioral assessments included object recognition and fear‐motivated memory tests. Twenty‐four hours after the final treatment, animals were euthanized for neurochemical and molecular analyses. Levels of the endocannabinoids anandamide (AEA) and 2‐arachidonoylglycerol (2‐AG) were measured using high‐performance liquid chromatography. Gene expression of cannabinoid receptors CB1 and CB2, as well as enzymes involved in the synthesis and degradation of endocannabinoids (NAPE‐PLD, DAGL‐A, FAAH, and MGLL), was evaluated in the hippocampus by RT‐qPCR. The results demonstrated that CBD treatment produced memory improvements in the object recognition task comparable to those observed with estradiol. Ovariectomy‐induced impairments in fear‐motivated memory were completely reversed by both CBD and estradiol treatments. Additionally, CBD reduced the expression of FAAH and MGLL, resulting in increased hippocampal levels of AEA and 2‐AG, effects similar to those observed with hormone therapy. Estradiol also increased NAPE‐PLD expression, contributing to elevated AEA levels. Overall, the findings suggest that CBD exerts a protective effect on memory comparable to standard estrogen therapy, supporting its therapeutic potential for menopause‐related cognitive impairments.
- 22 October 2024
- Published by Elsevier in Neuropharmacology
- Vol. 262, 110196
Cannabidiol partially rescues behavioral, neuroinflammatory and endocannabinoid dysfunctions stemming from maternal obesity in the adult offspring
- 22 October 2024
- Published by Elsevier in Neuropharmacology
- Vol. 262, 110196
Cannabidiol partially rescues behavioral, neuroinflammatory and endocannabinoid dysfunctions stemming from maternal obesity in the adult offspring
- 29 March 2024
- Published by Springer Nature in Neurochemical Research
- Vol. 49 (7) , 1762-1781
Lactate Protects Microglia and Neurons from Oxygen–Glucose Deprivation/Reoxygenation
Lactate has received attention as a potential therapeutic intervention for brain diseases, particularly those including energy deficit, exacerbated inflammation, and disrupted redox status, such as cerebral ischemia. However, lactate roles in metabolic or signaling pathways in neural cells remain elusive in the hypoxic and ischemic contexts. Here, we tested the effects of lactate on the survival of a microglial (BV-2) and a neuronal (SH-SY5Y) cell lines during oxygen and glucose deprivation (OGD) or OGD followed by reoxygenation (OGD/R). Lactate signaling was studied by using 3,5-DHBA, an exogenous agonist of lactate receptor GPR81. Inhibition of lactate dehydrogenase (LDH) or monocarboxylate transporters (MCT), using oxamate or 4-CIN, respectively, was performed to evaluate the impact of lactate metabolization and transport on cell viability. The OGD lasted 6 h and the reoxygenation lasted 24 h following OGD (OGD/R). Cell viability, extracellular lactate concentrations, microglial intracellular pH and TNF-ɑ release, and neurite elongation were evaluated. Lactate or 3,5-DHBA treatment during OGD increased microglial survival during reoxygenation. Inhibition of lactate metabolism and transport impaired microglial and neuronal viability. OGD led to intracellular acidification in BV-2 cells, and reoxygenation increased the release of TNF-ɑ, which was reverted by lactate and 3,5-DHBA treatment. Our results suggest that lactate plays a dual role in OGD, acting as a metabolic and a signaling molecule in BV-2 and SH-SY5Y cells. Lactate metabolism and transport are vital for cell survival during OGD. Moreover, lactate treatment and GPR81 activation during OGD promote long-term adaptations that potentially protect cells against secondary cell death during reoxygenation. Graphical Abstract
- 29 March 2024
- Published by Springer Nature in Neurochemical Research
- Vol. 49 (7) , 1762-1781
Lactate Protects Microglia and Neurons from Oxygen–Glucose Deprivation/Reoxygenation
Lactate has received attention as a potential therapeutic intervention for brain diseases, particularly those including energy deficit, exacerbated inflammation, and disrupted redox status, such as cerebral ischemia. However, lactate roles in metabolic or signaling pathways in neural cells remain elusive in the hypoxic and ischemic contexts. Here, we tested the effects of lactate on the survival of a microglial (BV-2) and a neuronal (SH-SY5Y) cell lines during oxygen and glucose deprivation (OGD) or OGD followed by reoxygenation (OGD/R). Lactate signaling was studied by using 3,5-DHBA, an exogenous agonist of lactate receptor GPR81. Inhibition of lactate dehydrogenase (LDH) or monocarboxylate transporters (MCT), using oxamate or 4-CIN, respectively, was performed to evaluate the impact of lactate metabolization and transport on cell viability. The OGD lasted 6 h and the reoxygenation lasted 24 h following OGD (OGD/R). Cell viability, extracellular lactate concentrations, microglial intracellular pH and TNF-ɑ release, and neurite elongation were evaluated. Lactate or 3,5-DHBA treatment during OGD increased microglial survival during reoxygenation. Inhibition of lactate metabolism and transport impaired microglial and neuronal viability. OGD led to intracellular acidification in BV-2 cells, and reoxygenation increased the release of TNF-ɑ, which was reverted by lactate and 3,5-DHBA treatment. Our results suggest that lactate plays a dual role in OGD, acting as a metabolic and a signaling molecule in BV-2 and SH-SY5Y cells. Lactate metabolism and transport are vital for cell survival during OGD. Moreover, lactate treatment and GPR81 activation during OGD promote long-term adaptations that potentially protect cells against secondary cell death during reoxygenation. Graphical Abstract
- 1 November 2019
- Published by Elsevier in Neuroscience Letters
- Vol. 712, 134505
Social support favors extinction and impairs acquisition of both short- and long-term contextual fear conditioning memory
- 1 November 2019
- Published by Elsevier in Neuroscience Letters
- Vol. 712, 134505
Social support favors extinction and impairs acquisition of both short- and long-term contextual fear conditioning memory